{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T21:10:45Z","timestamp":1784927445463,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"24","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T00:00:00Z","timestamp":1776297600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Case Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.jaccas.2026.108330","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T09:13:04Z","timestamp":1778836384000},"page":"108330","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fluoropyrimidine Cardiotoxicity With Overlapping Vasospastic and Pericardial Features"],"prefix":"10.1016","volume":"31","author":[{"given":"Adriana Elisa","family":"Vi\u00f1as-Mendieta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo A.","family":"Valencia-Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8395-8457","authenticated-orcid":false,"given":"Enrique","family":"Ruiz-Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8347-9523","authenticated-orcid":false,"given":"Alfonso","family":"Gonzalez-Trejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Karen","family":"Nieto-Dolores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauricio","family":"Garcia-Cardenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Dominguez-Linares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4820-1325","authenticated-orcid":false,"given":"Nilda","family":"Espinola-Zavaleta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.jaccas.2026.108330_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11864-020-0719-1","article-title":"Cardiotoxicities of 5-Fluorouracil and other fluoropyrimidines","volume":"21","author":"Shiga","year":"2020","journal-title":"Curr Treat Options Oncol"},{"issue":"1","key":"10.1016\/j.jaccas.2026.108330_bib2","first-page":"3","article-title":"Cardiovascular safety of 5-fluorouracil and capecitabine in colorectal cancer patients: real-world evidence","volume":"11","author":"Wong","year":"2025","journal-title":"Cardiooncology"},{"key":"10.1016\/j.jaccas.2026.108330_bib3","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1093\/eurheartj\/ehac244","volume":"43","author":"Lyon","year":"2022","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jaccas.2026.108330_bib4","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1253\/circj.CJ-66-0098","article-title":"Guidelines for diagnosis and treatment of patients with vasospastic angina (coronary spastic angina) (JCS 2013): \u2013 digest version","volume":"78","year":"2014","journal-title":"Circ J"},{"issue":"8","key":"10.1016\/j.jaccas.2026.108330_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1016\/j.ctrv.2013.03.005","article-title":"Cardiotoxicity in cancer patients treated with 5-fluorouracil or capecitabine: a systematic review of incidence, manifestations and predisposing factors","volume":"39","author":"Polk","year":"2013","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/j.jaccas.2026.108330_bib6","doi-asserted-by":"crossref","DOI":"10.1177\/1758835918780140","article-title":"5-Fluorouracil and cardiotoxicity: a review","volume":"10","author":"Sara","year":"2018","journal-title":"Ther Adv Med Oncol"},{"issue":"1","key":"10.1016\/j.jaccas.2026.108330_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1756-9966-31-60","article-title":"5-Fluorouracil induces apoptosis in rat cardiocytes through intracellular oxidative stress","volume":"31","author":"Lamberti","year":"2012","journal-title":"J Exp Clin Cancer Res"},{"issue":"2","key":"10.1016\/j.jaccas.2026.108330_bib8","first-page":"63","article-title":"5-fluorouracil induced cardiotoxicity in albino rats","volume":"27","author":"Kumar","year":"1995","journal-title":"Mater Med Pol"},{"issue":"7-8","key":"10.1016\/j.jaccas.2026.108330_bib9","first-page":"360","article-title":"[Pericarditis following 5-fluorouracil administration]","volume":"70","author":"Mar\u00e9chal","year":"2015","journal-title":"Rev Med Liege"},{"issue":"5","key":"10.1016\/j.jaccas.2026.108330_bib10","article-title":"Dual cardiotoxicity of capecitabine: coronary vasospasm and QT prolongation in a patient with gastric adenocarcinoma","volume":"31","author":"Dominguez-Linares","year":"2026","journal-title":"JACC Case Rep"},{"issue":"10","key":"10.1016\/j.jaccas.2026.108330_bib11","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/14740338.2017.1354987","article-title":"Cancer drugs and QT prolongation: weighing risk against benefit","volume":"16","author":"Menna","year":"2017","journal-title":"Expert Opin Drug Saf"}],"container-title":["JACC: Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926014890?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666084926014890?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T20:57:45Z","timestamp":1784926665000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666084926014890"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":11,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2666084926014890"],"URL":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.108330","relation":{},"ISSN":["2666-0849"],"issn-type":[{"value":"2666-0849","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluoropyrimidine Cardiotoxicity With Overlapping Vasospastic and Pericardial Features","name":"articletitle","label":"Article Title"},{"value":"JACC: Case Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaccas.2026.108330","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"108330"}}